About the Effort
Founded on the belief that the private sector is a powerful part of the solution, the US Rapid Action Consortium has a clear mission: to safely and effectively reopen the US economy faster.
With millions of lives impacted and billions of dollars being lost in economic activity each week, the US Rapid Action Consortium aims to create a COVID-19 rapid action testing system to better enable US businesses in creating safer workplaces.
The US Rapid Action Consortium is an expansion of a successful program led by the Creative Destruction Lab Rapid Screening Consortium (CDL RSC) in Canada, of which Genpact is a founding partner. Genpact, the Creative Destruction Lab, and COVID Collaborative have come together to launch this Consortium to rapidly accelerate a safe reopening of the US economy.
Scientists and experts agree that COVID-19 will not be fully eradicated anytime soon, and rapid antigen testing, along with other actions, are essential to public and workplace safety. Testing and vaccinations are two critical elements of an effective reopening strategy that will go hand in hand.
CRITERIA TO JOIN
Each company must:
- Make available 2-3 dedicated resources for this effort
- Enable IT teams to connect to the central data system and set up the company's local pilot dashboard
- Provide funding to purchase tests and cover the IT set up
- Commit to 60 hours of “pay it forward" time (over 10 weeks) for information sharing and supporting current and future participating companies